The Biologics News and Reports Portal

Show Cart

La Merie Publishing

Results 21 - 40 of 192

Jun 2019 CD38-Targeted Antibody & Cell Therapy – Target Pipeline List 06/2019

150.00 €

Jun 2019 Report Package: Bispecific Antibodies

2,520.00 €

3,150.00 €

(Discount: 20.00%)

Jun 2019 Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases

800.00 €

Jun 2019 T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis

2,350.00 €

May 2019 CD33-Targeted Antibody & Cell Therapy – Target Pipeline List 05/2019

150.00 €

Apr 2019 CD40 Agonists – Target Pipeline List 04/2019

150.00 €

Mar 2019 Blockbuster Biologics 2018: Sales of Recombinant Therapeutic Antibodies & Proteins

80.00 €

Jan 2019 DNA Vaccines for cancer, infectious & other diseases

400.00 €

Dec 2018 TFPI Inhibitors – Target Pipeline List

50.00 €

Dec 2018 Interleukin-33/Receptor Targeted Antibodies – Target Pipeline List 12/2018

75.00 €

Jul 2018 CXCR2, CCR2 & CCR4 Chemokine Receptor Antagonists – Target Pipeline List 07/2018

100.00 €

Jul 2018 Report Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators

1,440.00 €

2,400.00 €

(Discount: 40.00%)

Shopping cart

Cart empty

Latest report

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a landscape analysis of technologies, targets, business and financing from an industry perspective

Featured Products

Report bundle: Claudin 6, Cadherin 17, ROR1 and GPRC5D-Targeted Therapies: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

Latest Target Pipeline

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

Shopping cart

Cart empty

Latest report

Featured Products

Report bundle: Claudin 6, Cadherin 17, ROR1 and GPRC5D-Targeted Therapies: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

Latest Target Pipeline

ROR1-Targeted Therapy: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis

La Merie Publishing

Jun 2019 CD38-Targeted Antibody & Cell Therapy – Target Pipeline List 06/2019

Jun 2019 Report Package: Bispecific Antibodies

Jun 2019 Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases

Jun 2019 T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis

May 2019 CD33-Targeted Antibody & Cell Therapy – Target Pipeline List 05/2019

Apr 2019 CD40 Agonists – Target Pipeline List 04/2019

Mar 2019 Blockbuster Biologics 2018: Sales of Recombinant Therapeutic Antibodies & Proteins

Jan 2019 DNA Vaccines for cancer, infectious & other diseases

Dec 2018 TFPI Inhibitors – Target Pipeline List

Dec 2018 Interleukin-33/Receptor Targeted Antibodies – Target Pipeline List 12/2018

Nov 2018 Neulasta Biosimilars – Target Pipeline List 11/2018

Nov 2018 Avastin Biosimilars - Target Pipeline List 11/2018

Nov 2018 MerTK Inhibitors – Target Pipeline List 11/2018

Nov 2018 Humira Biosimilars – Target Pipeline List 11/2018

Aug 2018 CD40 Antagonists & CD40L Inhibitors – Target Pipeline List 08/2018

Aug 2018 Myostatin Inhibitors – Target Pipeline List 08/2018

Aug 2018 Interleukin-2 Receptor Agonists – Target Pipeline List 08/2018

Aug 2018 LRRK2 Inhibitors – Target Pipeline List 08/2018

Jul 2018 CXCR2, CCR2 & CCR4 Chemokine Receptor Antagonists – Target Pipeline List 07/2018

Jul 2018 Report Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing